Cardiovascular Drug Discovery Services

Innovative drugs for the cardiovascular system have been a hot topic of interest for medical and pharmacy researchers around the world. With specialized equipment platforms and an experienced research team, Ace Therapeutics can provide integrated R&D services to help our clients accelerate the development of cardiovascular drugs.

Current Trends in Cardiovascular Drug Research

There is a great deal of challenge involved in preventing and treating cardiovascular diseases in the public health and medical fields on a global scale. Currently, there are several popular research directions in the area of therapeutic drugs for cardiovascular disease.

• Novel Cholesterol-Lowering Drug Development
  Since cholesterol is a major component in the formation of atherosclerotic plaques, cholesterol-lowering medications are a common pharmacological strategy for the prevention and therapy of atherosclerosis-associated cardiovascular diseases.
• Novel Antithrombotic Drug Development
  In the field of coronary heart disease as well as coronary intervention, the development of novel antithrombotic drugs to reduce the occurrence of myocardial ischemic events and bleeding complications is a hot topic in the research field.
• Compounded Drugs for the Prevention of Cardiovascular Risk Events
  The development of combination drug therapy strategies to reduce the risk of cardiovascular risk events such as myocardial infarction and stroke is receiving increasing attention.

Fig. 1 Inflammatory cytokines and chemokines as therapeutic targets in heart failure. (Hanna A, and Frangogiannis NG, 2020)

Based on the experience in the field of cardiovascular disease research for a long time, Ace Therapeutics is able to provide our clients with R&D services for cardiovascular diseases, including identification and validation of cardiovascular disease-related targets, development of different types of cardiovascular disease drugs, as well as development of drug delivery systems.

Ace Therapeutics has always strived to provide research and development services that cover the preclinical cycle of drug discovery and development according to the customized needs of our clients. If you are interested in our services, please do not hesitate to contact us.

1. Hanna, A.; Frangogiannis, N.G. Inflammatory cytokines and chemokines as therapeutic targets in heart failure. Cardiovasc Drugs Ther. 2020, 34(6):849-863.